EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cathepsin S Knockdown Suppresses Endothelial Inflammation, Angiogenesis, and Complement Protein Activity under Hyperglycemic Conditions In Vitro by Inhibiting NF-κB Signaling

Shithima Sayed iD, Omar Faruq iD, Umma Hafsa Preya, Jee Taek Kim iD

International Journal of Molecular Sciences · 12.03.2023 · 24 (6) · 5428

DOI: 10.3390/ijms24065428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.03.2023. Verfasst von Shithima Sayed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea. Hauptthemen laut MEDLINE: Hyperglycemia, Diabetes Complications. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperglycemia plays a key role in the development of microvascular complications, endothelial dysfunction (ED), and inflammation. It has been demonstrated that cathepsin S (CTSS) is activated in hyperglycemia and is involved in inducing the release of inflammatory cytokines. We hypothesized that blocking CTSS might alleviate the inflammatory responses and reduce the microvascular complications and angiogenesis in hyperglycemic conditions. In this study, we treated human umbilical vein endothelial cells (HUVECs) with high glucose (HG; 30 mM) to induce hyperglycemia and measured the expression of inflammatory cytokines. When treated with glucose, hyperosmolarity could be linked to cathepsin S expression; however, many have mentioned the high expression of CTSS. Thus, we made an effort to concentrate on the immunomodulatory role of the CTSS knockdown in high glucose conditions. We validated that the HG treatment upregulated the expression of inflammatory cytokines and CTSS in HUVEC. Further, siRNA treatment significantly downregulated CTSS expression along with inflammatory marker levels by inhibiting the nuclear factor-kappa B (NF-κB) mediated signaling pathway. In addition, CTSS silencing led to the decreased expression of vascular endothelial markers and downregulated angiogenic activity in HUVECs, which was confirmed by a tube formation experiment. Concurrently, siRNA treatment reduced the activation of complement proteins C3a and C5a in HUVECs under hyperglycemic conditions. These findings show that CTSS silencing significantly reduces hyperglycemia-induced vascular inflammation. Hence, CTSS may be a novel target for preventing diabetes-induced microvascular complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperglycemiaDiabetes ComplicationsHumansNF-kappa BSignal TransductionGlucoseHuman Umbilical Vein Endothelial CellsInflammationRNA, Small InterferingCytokinesCathepsins

Stichwörter der Autor:innen

HUVECscathepsin Scathepsin S siRNAhyperglycemiainflammatory cytokinestransfection

Substanzen

NF-kappa BGlucoseRNA, Small InterferingCytokinescathepsin SCathepsins

Autor:innen und Institutionen

  • Department of Ophthalmology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea.
  • Biomedical Engineering Doctoral Program, Boise State University, Boise, ID 83725, USA.
  • Department of Ophthalmology, Chung-Ang University Hospital, Seoul 06974, Republic of Korea.

ORCID-Profile: Shithima Sayed, Omar Faruq, Jee Taek Kim

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Sayed, S., Faruq, O., Preya, U. H., & Kim, J. T. (2023). Cathepsin S Knockdown Suppresses Endothelial Inflammation, Angiogenesis, and Complement Protein Activity under Hyperglycemic Conditions In Vitro by Inhibiting NF-κB Signaling. International Journal of Molecular Sciences, 24(6), 5428. https://doi.org/10.3390/ijms24065428

Vancouver

Sayed S, Faruq O, Preya UH, Kim JT. Cathepsin S Knockdown Suppresses Endothelial Inflammation, Angiogenesis, and Complement Protein Activity under Hyperglycemic Conditions In Vitro by Inhibiting NF-κB Signaling. International Journal of Molecular Sciences. 2023;24(6):5428. doi:10.3390/ijms24065428

BibTeX
@article{Sayed2023,
  author = {Sayed, Shithima and Faruq, Omar and Preya, Umma Hafsa and Kim, Jee Taek},
  title = {Cathepsin S Knockdown Suppresses Endothelial Inflammation, Angiogenesis, and Complement Protein Activity under Hyperglycemic Conditions In Vitro by Inhibiting NF-κB Signaling},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {6},
  pages = {5428},
  doi = {10.3390/ijms24065428}
}
Kostenlos starten →